Patents Assigned to EMERAMED LIMITED
  • N,N--2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases
    Patent number: 11628151
    Abstract: According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in the therapeutic treatment of a neurodegenerative disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and/or amyotrophic lateral sclerosis.
    Type: Grant
    Filed: September 27, 2022
    Date of Patent: April 18, 2023
    Assignee: EMERAMED LIMITED
    Inventors: Boyd Eugene Haley, Ragnar Axel Theodor Klingberg
  • Method of supplementing the diet and ameliorating oxidative stress
    Patent number: 9907787
    Abstract: A method of supplementing a diet and ameliorating oxidative stress in a mammal includes administering a pharmaceutically effective amount of an active compound having the chemical structure: where n=1-4 and X is selected from the group consisting of hydrogen, lithium sodium, potassium, rubidium, cesium and francium.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: March 6, 2018
    Assignee: EMERAMED LIMITED
    Inventor: Boyd E. Haley
  • Use of N,N-bis-2-mercaptoethyl isophthalamide
    Patent number: 9782368
    Abstract: According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in regenerating ascorbate systemically and thus in the therapeutic treatment of chronic obstructive pulmonary disease.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: October 10, 2017
    Assignee: Emeramed Limited
    Inventors: Boyd Eugene Haley, Ragnar Axel Theodor Klingberg
  • Method of supplementing the diet and ameliorating oxidative stress
    Patent number: 9592209
    Abstract: A method of supplementing a diet and ameliorating oxidative stress in a mammal includes administering a pharmaceutically effective amount of an active compound having the chemical structure: where n=1-4 and X is selected from the group consisting of hydrogen, lithium sodium, potassium, rubidium, cesium and francium.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: March 14, 2017
    Assignee: EMERAMED LIMITED
    Inventor: Boyd E. Haley